Impact of HbA1c and comorbidities on choosing the next treatment

Several factors shape the choice of glucose-lowering treatment, including patient characteristics and comorbidities such as chronic kidney disease or heart disease. Learn how to weigh these factors and how to apply the patient-centred prescribing algorithm.

This activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours.

Learning Outcomes

1. Outline best practice approaches to selecting glucose-lowering therapies based on comorbidities and patient characteristics.
2. Critically reflect on your current approach to treatment selection.
3. Reflect on how prioritising comorbidities alongside HbA1c could reshape your longer-term approach to T2D management.

Provider

The Provider of this activity is Praxhub. Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com.